Swiss National Bank’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-1,560
Closed -$271K – 2650
2022
Q4
$271K Buy
1,560
+31
+2% +$20.4K ﹤0.01% 2653
2022
Q3
$1.47M Buy
1,529
+178
+13% +$177K ﹤0.01% 2090
2022
Q2
$905K Sell
1,351
-118
-8% -$73.1K ﹤0.01% 2419
2022
Q1
$1.02M Buy
1,469
+109
+8% +$84.1K ﹤0.01% 2396
2021
Q4
$1.23M Hold
1,360
– – ﹤0.01% 2354
2021
Q3
$1.37M Hold
1,360
– – ﹤0.01% 2269
2021
Q2
$883K Sell
1,360
-33
-2% -$22.9K ﹤0.01% 2524
2021
Q1
$1.03M Hold
1,393
– – ﹤0.01% 2337
2020
Q4
$1.08M Sell
1,393
-103
-7% -$81.2K ﹤0.01% 2251
2020
Q3
$1.49M Buy
1,496
+22
+1% +$23.3K ﹤0.01% 1862
2020
Q2
$1.53M Buy
1,474
+1,000
+211% +$1.01M ﹤0.01% 1858
2020
Q1
$385K Hold
474
– – ﹤0.01% 2273
2019
Q4
$592K Buy
474
+14
+3% +$22.6K ﹤0.01% 2372
2019
Q3
$618K Hold
460
– – ﹤0.01% 2283
2019
Q2
$816K Buy
+460
New +$704K ﹤0.01% 2223

Other funds holding GOSS

Swiss National Bank's GOSS Position: Q1 2023 in Review

Swiss National Bank sold out of Gossamer Bio (GOSS) in Q1 2023, closing a stake of 1,560 shares — an estimated $271K sold.

Swiss National Bank first reported a position in GOSS in Q2 2019 and held it in 15 quarters. The position peaked at $1.53M in Q2 2020. 110 funds tracked by Wall St. Rank hold GOSS as of Q1 2023.

  • Swiss National Bank reported no remaining Gossamer Bio position as of Q1 2023 after selling out during the quarter.
  • Swiss National Bank sold 1,560 Gossamer Bio shares in Q1 2023, an estimated $271K.
  • Swiss National Bank first reported a position in Gossamer Bio in Q2 2019 and held it in 15 quarters.
  • Swiss National Bank's Gossamer Bio position peaked at $1.53M in Q2 2020.
  • 110 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2023.

Based on Swiss National Bank's 13F filing for Q1 2023, filed 10 May 2023.